After a 3.5x growth over 2020(and 5.6x 2019), it still forecasts a 70% growth rate for 2022…it’s now net income positive vs a loss(q4, not full year), and shows an uptick in gross profit (85% vs full year 83%). I cannot find the cash flow statements…yet.

Any doctors/surgeons out there who can comment on this? After $ISRG , it’s my next largest medtech holding.